Circle8 Group (CIRC) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pacific Biosciences of California (PACB) has outperformed Circle8 Group (CIRC) over the past year, gaining 94.3% versus a loss of 84.7%. Over five years, PACB leads with a -88.8% price change compared with -99.7% for CIRC. Pacific Biosciences of California is the larger company by market cap ($700.9 million vs $52.5 million), about 13.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CIRC | PACB |
|---|---|---|
| Share price | $0.4587 | $2.26 |
| Market cap | $52.48M | $700.92M |
| 1-day change | -0.28% | -17.10% |
| YTD return | -65.41% | +45.45% |
| 1-year return | -84.67% | +94.29% |
| 5-year return | -99.67% | -88.85% |
| EPS (TTM) | $-2.14 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.56 | $3.44 |
| 52-week low | $0.313 | $1.07 |
| Distance from 52-week high | -89.94% | -34.45% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | -4.21% |
| Average volume | 3.06M | 10.10M |
| Shares outstanding | 114.41M | 310.83M |
| Employees | — | 485 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Pacific Biosciences of California is about 13.4 times larger than Circle8 Group by market value ($700.92M vs $52.48M).
- PACB has outperformed CIRC by 179.0 percentage points over the past year.
About Pacific Biosciences of California
PACB stock →Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees
CIRC vs PACB FAQ
Which is bigger, Circle8 Group or Pacific Biosciences of California?
Pacific Biosciences of California (PACB) is larger, with a market capitalization of $700.92M compared with $52.48M for Circle8 Group (CIRC).
Which stock has performed better over the past year, CIRC or PACB?
PACB returned +94.29% over the past 12 months, compared with -84.67% for CIRC (price return, excluding dividends). Past performance does not predict future results.
Are Circle8 Group and Pacific Biosciences of California in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.